Targeting antigens to cDC1 in the form of peptide epitopes or whole antigen covalently linked to Clec9a Ab elicited CD8 + cytotoxic T cell responses as well as humoral and CD4 + T cell responses in mice [6], reduced viremia [7], and inhibited tumor growth [8]. The gene discussed is CLEC9A; the disease is neoplasm.